Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
4 minute read

Here’s Where To Buy Legal Weed: Florida’s Thriving Cannabis Landscape And More New Marijuana Stores In US And Canada

By Jelena Martinovic
May 13, 11:18 AM
In anticipation of the outcome of Florida's Measure 3, cannabis giants are racing to bolster their retail footprint statewide. In California, four new cannabis stores kicked off sales recently. New York's cannabis retail footprint continues to grow. Five states each opened a new cannabis store, while Canna Cabana retail presence expands in Canada,

CSE:GTII

Read More
2 minute read

Medical Marijuana Giant Trulieve, Backer Of Florida’s Recreational Cannabis Ballot, Narrows Loss, Reports Uptick In Q1 Revenue, Gross Profit

By Jelena Martinovic
May 9, 8:49 AM
Trulieve Cannabis Corp. announced on Thursday its first quarter results for the three months ended March 31, 2024. The Tallahassee, Florida-based medical cannabis giant reported revenue of $298 million for the first quarter of fiscal 2024, representing an increase of 4% sequentially and year-over-year, with 96% of revenue from retail sales.

AYRWF

Read More
2 minute read

EXCLUSIVE: ‘Cannabis Is Just Getting Started,’ Says This Top Stock Expert Who Knows How To Capitalize On Swing Trades

By Jelena Martinovic
May 3, 1:17 PM
"Cannabis is just getting started and there's going to be a lot of companies getting ready to take advantage of this massive growth cycle, government reform, news states, opening new opportunities and one day, interstate commerce." That's according to Benzinga's cannabis stock expert, Michael Berger, who is on a mission to uncover the most promising marijuana stocks poised for growth, even in a dull market.

CSE:CURA

Read More
3 minute read

Cocaine, Meth Decriminalization In Maine, NY Weed Market Expands, Cannabis Reg Updates In AR And FL

By Jelena Martinovic
January 17, 10:17 AM
On Friday, a New York regulator green-lighted two more marijuana multistate operators to transition to the recreational market from the medical. Fiorello Pharmaceuticals Inc. - owned by Green Thumb Industries Inc and running dispensaries in Manhattan, Long Beach, Rochester and Half Moon - and Citiva Medical LLC - owned by iAnthus Capital Holdings Inc. and operating medical dispensaries doing business as "Be" in Brooklyn, Wappingers Falls, Staten Island and Ithaca– were approved by the members of New York Cannabis Control Board (CCB) in the anonymous vote. In the meantime, on Jan. 12, Arkansans for Patient Access, a ballot committee, submitted a proposed ballot initiative to Arkansas Attorney General Tim Griffin to amend Amendment 98, the state's medical marijuana amendment. In Maine, a new push seeks to decriminalize the possession of small quantities of illegal drugs and allocate resources towards treating substance use disorder instead of enforcing punitive measures. More Floridians are opting to register as medical marijuana patients, at least according to the 2024 Physician Certification Pattern Review annual report that highlighted figures from fiscal year 2023.

CSE:GTII

Read More
3 minute read

Cannabis Stocks And ETFs Trading Higher As Government Recommendations Ignite Hope For Industry

By Jelena Martinovic
January 16, 1:56 PM
Cannabis stocks and ETFs opened higher on Tuesday following the release of documents related to the Department of Health and Human Service's (HHS) review of cannabis. Investors are optimistic about potential regulatory changes that could benefit the cannabis industry after the US government released 252 pages of documents confirming the HHS's recommendation that the DEA reschedule cannabis as Schedule III under the Controlled Substances Act. The documents state that cannabis has a currently accepted medical use in treatment and potential for abuse less than drugs in Schedules I and II. In August, the Assistant Secretary for Health wrote a letter to the DEA calling for marijuana to be reclassified. The Secretary of HHS has confirmed that his department shared a comprehensive scientific review with the DEA in response to President Joe Biden's scheduling directive.

ACB